ImClone Investigational Site

Temple, Texas 76508

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Colorectal Cancer, Colorectal Neoplasms, Metastases, Neoplasm, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer — Completed
• A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Completed
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed
• Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) — Completed